星展发表报告指，维他奶国际全年度业绩与早前盈喜一致。该行预期维他奶的中国内地业务将带动稳定增长，而其他市场包括澳洲、新西兰、新加坡的亏损将收窄。该行维持对其“持有”评级，目标价由9.5港元下调至8.8港元，相当于预测市盈率27倍。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.